GRWD 0715
Alternative Names: GRWD-0715Latest Information Update: 06 Jun 2024
At a glance
- Originator Grey Wolf Therapeutics
- Class Small molecules
- Mechanism of Action ERAP1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes
Highest Development Phases
- Preclinical Autoimmune disorders